Intravascular ultrasound (IVUS) linked with improved health outcomes in largest-ever real-world analysis of lower extremity peripheral vascular interventions
08 nov. 2021 09h00 HE
|
Royal Philips
November 8, 2021 Independent analysis includes Centers for Medicare & Medicaid Services (CMS) data from over 700,000 peripheral arterial and peripheral venous intervention patients Data...
TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease
02 nov. 2021 10h00 HE
|
Royal Philips
November 2, 2021 Philips debuts three new solutions in the North American market that will help drive procedural innovation and workflow efficiency, adding to the company’s ecosystem of...
Radboud university medical center study sets new milestone with 90% diagnostic accuracy of lung nodules suspected of cancer using Philips technology for bronchoscopic procedures
06 oct. 2021 08h00 HE
|
Royal Philips
October 4, 2021 Radboud university medical center study sets new milestone with 90% diagnostic accuracy of lung nodules suspected of cancer using Philips technology for bronchoscopic procedures ...
Clinical experts establish first-ever global consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease interventions
05 oct. 2021 11h00 HE
|
Royal Philips
October 5, 2021 First global analysis of IVUS by interventional cardiology, interventional radiology, and vascular surgery experts in peripheral vascular disease (PVD) interventionsConsensus...
Philips receives FDA Breakthrough Device Designation for laser-assisted IVC filter removal device
21 juil. 2021 09h00 HE
|
Royal Philips
July 21, 2021 FDA Breakthrough Device Designation is granted to novel medical devices that have the potential to provide more effective treatmentIt is estimated that in the United States more than...
Philips announces first patient treated with its new real-time 3D intracardiac echocardiography catheter – VeriSight Pro
01 juil. 2021 09h00 HE
|
Royal Philips
July 01, 2021 FDA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has potential to improve standard of care for structural heart disease and electrophysiology procedures...
Philips announces first patient enrollment in DEFINE GPS global multicenter study to assess superiority of PCI procedures guided by co-registered iFR and interventional angiography
22 juin 2021 09h00 HE
|
Royal Philips
June 22, 2021 First patient enrolled in global randomized controlled trial with up to 3,200 participants at 100 sites comparing patient outcomes after percutaneous coronary intervention (PCI)...
Philips announces European availability of innovations to advance personalized and efficient cardiac care at EuroPCR 2021
18 mai 2021 04h00 HE
|
Royal Philips
May 18, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the European availability of new innovations in its unique...
Philips introduces integrated Interventional Hemodynamic System with Patient Monitor IntelliVue X3 to improve workflow and patient focus during image-guided procedures at ACC.21
14 mai 2021 04h00 HE
|
Royal Philips
May 14, 2021 Continuous monitoring provides informed, timely clinical decision making and comprehensive, gap-free patient records in the cath lab and beyond Amsterdam, the Netherlands –...
Five-year patient-level meta-analysis of ILLUMENATE EU RCT and Pivotal study results confirms safety profile of Philips Stellarex .035” low-dose Drug-Coated Balloon
20 avr. 2021 11h25 HE
|
Royal Philips
April 20, 2021 Stellarex is the only Drug-Coated Balloon (DCB) to consistently demonstrate no difference in mortality every year through five years when compared with percutaneous transluminal...